HisS from Chlamydia trachomatis
    3.
    发明授权
    HisS from Chlamydia trachomatis 失效
    HisS来自沙眼衣原体

    公开(公告)号:US06187561B1

    公开(公告)日:2001-02-13

    申请号:US09210009

    申请日:1998-12-11

    IPC分类号: C12D2106

    CPC分类号: C12N9/93 A61K38/00 A61K39/00

    摘要: The invention provides hisS polynucleotides which encode hisS polypeptide, polynucleotides related thereto, and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing the hisS polynucleotides and polypeptides to screen for antibacterial compounds and for the detection of pathogens.

    摘要翻译: 本发明提供了编码hisS多肽的HisS多核苷酸,与其相关的多核苷酸,以及通过重组技术产生此类多肽的方法。 还提供了利用hisS多核苷酸和多肽筛选抗菌化合物和检测病原体的方法。

    Gene encoding MNR2 and uses thereof

    公开(公告)号:US06387656B1

    公开(公告)日:2002-05-14

    申请号:US09162524

    申请日:1998-09-29

    IPC分类号: C12D2106

    CPC分类号: C07K14/47 A01K2217/05

    摘要: This invention provides an isolated nucleic acid molecule encoding a motor neuron restricted pattern, MNR2, protein. This invention provides an isolated nucleic acid molecule of at least 15 contiguous nucleotides capable of specifically hybridizing with a unique sequence included within the sequence of the nucleic acid molecule encoding a MNR2 protein. This invention provides a purified MNR2 protein, a polyclonal and monoclonal antibody directed to an epitope of an MNR2 protein. This invention provides a method of inducing differentiation somatic motor neurons which comprises expressing MNR2 protein in any neural progenitor cells. This invention provides a transgenic animal which expresses an MNR2 protein. This invention provides a pharmaceutical composition comprising a MNR2 protein and pharmaceutically acceptable carrier. This invention provides methods of treating subjects afflicted with an abnormality associated with a lack of normally functioning motor neurons, neurodegenerative disease, an acute nervous system injury and a neuromuscular disease which comprises contacting the subject with a pharmaceutical composition comprising a MNR2 protein and pharmaceutically acceptable carrier. This invention provides a functionally equivalent analog of MNR2 that induces or prevents MNR2 differentiation of neural progenitor cells.